The transcriptomic changes observed in human AD brain samples are the results of all the phenomena such as Aβ and tau pathologies, neurodegeneration and neuroinflammation that arise in a specific spatio-temporal manner. This evidence concerns the gene MAPT and Alzheimer disease.